首页> 外文期刊>Pharmacology & Pharmacy >Antibiotic Use in a Cohort of Extremely Low Birth Weight Neonates: Focus on Off-Label Uses and Prescription Behaviour
【24h】

Antibiotic Use in a Cohort of Extremely Low Birth Weight Neonates: Focus on Off-Label Uses and Prescription Behaviour

机译:一组极低出生体重的新生儿中的抗生素使用:关注非标签使用和处方行为

获取原文
           

摘要

Aim: To analyse antibiotic prescriptions in a cohort of extremely low birth weight neonates admitted to Italian level III Neonatal intensive Care Units. Methods: An online questionnaire was used to collect detailed information for each newborn. Antibiotic prescriptions were classified about their license status and compared with British National Formulary for Children (BNFC) and with a practical guide prepared by the Italian Society of Neonatology (ISN). Results: During the study period (May-July 2014) among 93 neonates admitted to 30 Italian Neonatal intensive Care Units, 56 (60%) received at least an antibiotic (92 prescriptions in total). Ampicillin, gentamicin and vancomycin were the antibiotics most commonly used for the prevention/treatmen t of bacterial infections. 56/92 antibiotic prescriptions (61%) resulted off-label mainly as regards dosing frequency, while 13 prescriptions (14%) regarded antibiotics used in absence of specific indication for newborns (meropenem, imipenem, piperacillin/tazobactam, clindamycin, clarithromycin ). 50/56 neonates (89.3%) received at least one off-label antibiotic prescription. Differences have been observed in dosing regimens between current study and recommendations contained in BNFC, while prescriptions adhered more frequently to ISN indications. Conclusions: Our results confirm the high prevalence of off-label antibiotic use in ELBW neonates and underline a better adherence to indications based on clinical practice.
机译:目的:分析一组入选意大利III级新生儿重症监护病房的极低出生体重新生儿的抗生素处方。 方法:使用在线调查表收集每个新生儿的详细信息。对抗生素处方进行了分类,并与英国国家儿童处方药(BNFC)和意大利新生儿医学学会(ISN)编写的实用指南进行了比较。 结果:在研究期间(2014年5月至7月),共有30名意大利新生儿重症监护病房的93名新生儿中,有56名(60%)至少接受了抗生素治疗(总共92处方)。氨苄西林,庆大霉素和万古霉素是最常用于预防/治疗细菌感染的抗生素。 56/92抗生素处方(61%)主要导致服药频率不合格,而13处方(14%)认为在没有具体适应症的新生儿(美罗培南,亚胺培南,哌拉西林/他唑巴坦,克林霉素,克拉霉素)。 50/56名新生儿(89.3%)接受了至少一份标签外抗生素处方。目前的研究与BNFC所含建议之间的给药方案存在差异,而处方更频繁地遵循ISN适应症。 结论:我们的结果证实了ELBW新生儿中标签外抗生素的普遍使用,并强调了基于临床实践对适应症的更好依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号